Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content Using 3.0 Tesla Magnetic Resonance Imaging Proton Density Fat Fraction Software in Patients of T2DM: Prospective Open Label Case Control 16 Weeks Proof of Concept Study

NCT05939921 is registered in ClinicalTrials.gov with Diabetes Foundation, India as lead sponsor.

NCT NCT05939921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content Using 3.0 Tesla Magnetic Resonance Imaging Proton Density Fat Fraction Software in Patients of T2DM: Prospective Open Label Case Control 16 Weeks Proof of Concept Study
Lead sponsor
Diabetes Foundation, India
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
June 30, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2diabetes